<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>

    <title>
                    Pharmaceuticals and Biotech |
                            Media Room |
                        Newswire
            </title>
    <link>https://co.newswire.com/</link>
    <description>Latest news from Newswire</description>

    <atom:link href="https://www.newswire.com/newsroom/rss/industries-pharmaceuticals-and-biotech"
        rel="self" type="application/rss+xml" />

                                    <item>
        <title>Senior Pharma and Biotech Leaders to Convene for Industry Forum at San Francisco CEO Ahead of JP Morgan Healthcare Conference</title>
                    <link>https://www.newswire.com/news/senior-pharma-and-biotech-leaders-to-convene-for-industry-forum-at-san-22679232</link>
            <guid>https://www.newswire.com/news/senior-pharma-and-biotech-leaders-to-convene-for-industry-forum-at-san-22679232</guid>
                <description></description>
        <pubDate>Tue, 09 Dec 2025 12:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Pace(R) Appoints Ken Beyer as Chief Executive Officer</title>
                    <link>https://www.newswire.com/news/pace-r-appoints-ken-beyer-as-chief-executive-officer-22686729</link>
            <guid>https://www.newswire.com/news/pace-r-appoints-ken-beyer-as-chief-executive-officer-22686729</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Technology Veteran Brings Decades of Leadership to Guide the Nation&#039;s Largest Laboratory Services Network Through Next Phase of Strategic Growth&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Fri, 05 Dec 2025 20:15:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Frank Tagliaferri, Ph.D. Featured in Panel Session on Advancing Oral Drug Delivery Beyond Lipinski&#039;s Rule of 5</title>
                    <link>https://www.newswire.com/news/frank-tagliaferri-ph-d-featured-in-panel-session-on-advancing-oral-22686012</link>
            <guid>https://www.newswire.com/news/frank-tagliaferri-ph-d-featured-in-panel-session-on-advancing-oral-22686012</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Chief Scientific Officer of Pace&amp;reg; Life Sciences Joins Industry Leaders at Advancing Drug Development Forum (ADDF) to Collaborate on Technologies for Non-Traditional Molecules&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Fri, 05 Dec 2025 14:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>GraphiteRx and Mark Cuban Cost Plus Drugs Deepen Partnership to Advance Availability of Lower-Cost Medications</title>
                    <link>https://www.newswire.com/news/graphiterx-and-mark-cuban-cost-plus-drugs-deepen-partnership-to-22686014</link>
            <guid>https://www.newswire.com/news/graphiterx-and-mark-cuban-cost-plus-drugs-deepen-partnership-to-22686014</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Powering the Cost Plus Marketplace for Businesses Through Transparency, Innovation and Trust&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 04 Dec 2025 20:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>GEN Announces New Positive Phase 1 Trial Data of the Investigational Drug SUL-238 for Alzheimer&#039;s and Other Neurodegenerative Diseases</title>
                    <link>https://www.newswire.com/news/gen-announces-new-positive-phase-1-trial-data-of-the-investigational-22683812</link>
            <guid>https://www.newswire.com/news/gen-announces-new-positive-phase-1-trial-data-of-the-investigational-22683812</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Phase 1 results show that SUL-238 is safe, well-tolerated, and demonstrates favorable pharmacokinetics with high CSF penetration in healthy elderly volunteers, supporting its advancement into further clinical development for Alzheimer&#039;s and other neurodegenerative diseases.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 02 Dec 2025 05:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Icreon Achieves Platinum Partner Status With Optimizely</title>
                    <link>https://www.newswire.com/news/icreon-achieves-platinum-partner-status-with-optimizely-22678929</link>
            <guid>https://www.newswire.com/news/icreon-achieves-platinum-partner-status-with-optimizely-22678929</guid>
                <description>&lt;p&gt;&lt;strong&gt;Platinum Status Demonstrates Icreon&#039;s Unmatched Digital Experience Capabilities for Enterprise Clients&lt;/strong&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 20 Nov 2025 15:45:00 +0000</pubDate>
    </item>
                                                <item>
        <title>CenExel Hosts Comprehensive Good Clinical Practice (GCP) Training to Strengthen Clinical Excellence Across Network</title>
                    <link>https://www.newswire.com/news/cenexel-hosts-comprehensive-good-clinical-practice-gcp-training-to-22677460</link>
            <guid>https://www.newswire.com/news/cenexel-hosts-comprehensive-good-clinical-practice-gcp-training-to-22677460</guid>
                <description></description>
        <pubDate>Thu, 20 Nov 2025 14:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>C&amp;F Launches Next Best Action Offering to Transform Sales Effectiveness in Life Sciences</title>
                    <link>https://www.newswire.com/news/c-f-launches-next-best-action-offering-to-transform-sales-22674815</link>
            <guid>https://www.newswire.com/news/c-f-launches-next-best-action-offering-to-transform-sales-22674815</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Strong data foundations and AI-driven insights help pharmaceutical and animal health companies deliver the right message to the right stakeholder, at the right time.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Sun, 16 Nov 2025 14:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Nemysis Limited Announces Investment by Kolinpharma Through Its Parent Company IGEA Holding S.p.A.</title>
                    <link>https://www.newswire.com/news/nemysis-limited-announces-investment-by-kolinpharma-through-its-parent-22674888</link>
            <guid>https://www.newswire.com/news/nemysis-limited-announces-investment-by-kolinpharma-through-its-parent-22674888</guid>
                <description></description>
        <pubDate>Fri, 14 Nov 2025 10:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>New Study From GENinCode Shows Polygenic Risk Scores Improve the Accuracy of Cardiovascular Disease Risk Prediction</title>
                    <link>https://www.newswire.com/news/new-study-from-genincode-shows-polygenic-risk-scores-improve-the-22674078</link>
            <guid>https://www.newswire.com/news/new-study-from-genincode-shows-polygenic-risk-scores-improve-the-22674078</guid>
                <description></description>
        <pubDate>Wed, 12 Nov 2025 12:15:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Repair Biotechnologies Presents Preclinical Data at American Heart Association&#039;s Scientific Sessions 2025 Showing Regression of Atherosclerotic Plaque With REP-0003 Treatment</title>
                    <link>https://www.newswire.com/news/repair-biotechnologies-presents-preclinical-data-at-american-heart-22673107</link>
            <guid>https://www.newswire.com/news/repair-biotechnologies-presents-preclinical-data-at-american-heart-22673107</guid>
                <description></description>
        <pubDate>Tue, 11 Nov 2025 14:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Omnix Medical and Prevail Partners, LLC Announce Strategic and Financial Partnership</title>
                    <link>https://www.newswire.com/news/omnix-medical-and-prevail-partners-llc-announce-strategic-and-22670615</link>
            <guid>https://www.newswire.com/news/omnix-medical-and-prevail-partners-llc-announce-strategic-and-22670615</guid>
                <description></description>
        <pubDate>Thu, 06 Nov 2025 19:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>DistillerSR and Elsevier to Collaborate on the Integration of Elsevier&#039;s Embase(R) and DistillerSR&#039;s Evidence Management Platform</title>
                    <link>https://www.newswire.com/news/distillersr-and-elsevier-to-collaborate-on-the-integration-of-22667014</link>
            <guid>https://www.newswire.com/news/distillersr-and-elsevier-to-collaborate-on-the-integration-of-22667014</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;DistillerSR&#039;s literature review platform to provide turn-key integrated access to Embase&#039; API, greatly enhancing and simplifying the review process&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 04 Nov 2025 16:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Cambridge Isotope Laboratories, Inc. Unveils ISOAPI-D - a New Standard in Deuterated Reagents for Pharmaceutical Innovation - at CPhI Frankfurt 2025</title>
                    <link>https://www.newswire.com/news/cambridge-isotope-laboratories-inc-unveils-isoapi-d-a-new-standard-in-22661929</link>
            <guid>https://www.newswire.com/news/cambridge-isotope-laboratories-inc-unveils-isoapi-d-a-new-standard-in-22661929</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;With ISOAPI-D, CIL offers pharmaceutical partners a secure, global supply of deuterated reagents - manufactured to the highest quality standards for faster, more efficient API development.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Mon, 27 Oct 2025 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>NEW SURVEY: Four in Five Americans Support Reforms to the Patent System to Lower Drug Prices</title>
                    <link>https://www.newswire.com/news/new-survey-four-in-five-americans-support-reforms-to-the-patent-system-22660566</link>
            <guid>https://www.newswire.com/news/new-survey-four-in-five-americans-support-reforms-to-the-patent-system-22660566</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;A new report from the Franklin &amp;amp; Marshall&#039;s Center for Opinion Research and the Initiative for Medicines, Access &amp;amp; Knowledge (I-MAK) reveal Americans&#039; top concerns on drug pricing.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Mon, 20 Oct 2025 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Next Gen Diagnostics Showcases Low-Cost, Automated WGS-Based Transmission Detection Service at ID Week</title>
                    <link>https://www.newswire.com/news/next-gen-diagnostics-showcases-low-cost-automated-wgs-based-22659662</link>
            <guid>https://www.newswire.com/news/next-gen-diagnostics-showcases-low-cost-automated-wgs-based-22659662</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Visit NGD at Booth #712 to learn more about the NGD system, which automates both sample preparation and bioinformatics, as well as generates actionable reports for Infection Prevention teams.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 16 Oct 2025 15:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Repair Biotechnologies Announces Appointment of Noted Endocrinologist Prof. Frederick J. Raal to Scientific Advisory Board</title>
                    <link>https://www.newswire.com/news/repair-biotechnologies-announces-appointment-of-noted-cardiologist-22657067</link>
            <guid>https://www.newswire.com/news/repair-biotechnologies-announces-appointment-of-noted-cardiologist-22657067</guid>
                <description></description>
        <pubDate>Thu, 16 Oct 2025 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>CenExel Announces Formation of Task Forces to Advance Patient-Focused Clinical Research</title>
                    <link>https://www.newswire.com/news/cenexel-announces-formation-of-task-forces-to-advance-patient-focused-22659306</link>
            <guid>https://www.newswire.com/news/cenexel-announces-formation-of-task-forces-to-advance-patient-focused-22659306</guid>
                <description></description>
        <pubDate>Thu, 16 Oct 2025 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Owkin Launches K Pro: The First Agentic AI Co-Pilot for Biopharma Powered by Biological Reasoning Models</title>
                    <link>https://www.newswire.com/news/owkin-launches-k-pro-the-first-agentic-ai-co-pilot-for-biopharma-22659156</link>
            <guid>https://www.newswire.com/news/owkin-launches-k-pro-the-first-agentic-ai-co-pilot-for-biopharma-22659156</guid>
                <description>&lt;ul&gt;&lt;li&gt;&lt;p&gt;&lt;i&gt;&lt;strong&gt;Enterprise platform, queried through natural language, to help pharma, biotech, and investors make better decisions.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;&lt;/li&gt;&lt;li&gt;&lt;p&gt;&lt;i&gt;&lt;strong&gt;High-quality biological patient data, enriched and integrated for use by AI agents.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;&lt;/li&gt;&lt;/ul&gt;</description>
        <pubDate>Thu, 16 Oct 2025 05:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Next Gen Diagnostics Expands U.S. Operations With New Lab in Kendall Square</title>
                    <link>https://www.newswire.com/news/next-gen-diagnostics-expands-u-s-operations-with-new-lab-in-kendall-22658524</link>
            <guid>https://www.newswire.com/news/next-gen-diagnostics-expands-u-s-operations-with-new-lab-in-kendall-22658524</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Move positions company at the heart of Cambridge&#039;s innovation ecosystem to accelerate growth and collaboration in infection prevention.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 14 Oct 2025 20:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>INNOPOLIS K-Startup Showcase Bridges Korean Deep-Tech and U.S. Venture Capital</title>
                    <link>https://www.newswire.com/news/innopolis-k-startup-showcase-bridges-korean-deep-tech-and-u-s-venture-22657633</link>
            <guid>https://www.newswire.com/news/innopolis-k-startup-showcase-bridges-korean-deep-tech-and-u-s-venture-22657633</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Organized by Korea Innovation Foundation and Luceque Global Group, the event spotlights Korean innovation in biotech, AI, quantum technology, semiconductors, mobility, and solar panel recycling solution.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 14 Oct 2025 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Peek Healthcare Technologies, Inc. (&#039;Peek&#039;) Launches Direct-to-Employer and Direct-to-Patient Pricing for IMULDOSA(R) (ustekinumab-srlf) (Stelara(R) Biosimilar)</title>
                    <link>https://www.newswire.com/news/peek-healthcare-technologies-inc-peek-launches-direct-to-employer-and-22654028</link>
            <guid>https://www.newswire.com/news/peek-healthcare-technologies-inc-peek-launches-direct-to-employer-and-22654028</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;PeekDirect&amp;trade; Delivers Transparent and Affordable Pricing for Brand and Specialty Drugs to Reduce Prescription Costs for Employers and Patients&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 08 Oct 2025 16:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Belhaven Biopharma Initiates a Pivotal Biocomparability Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of Nasdepi(R) vs. Epinephrine Intramuscular Injections</title>
                    <link>https://www.newswire.com/news/belhaven-biopharma-initiates-a-pivotal-biocomparability-study-to-22654020</link>
            <guid>https://www.newswire.com/news/belhaven-biopharma-initiates-a-pivotal-biocomparability-study-to-22654020</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Belhaven&#039;s Investigational New Drug (IND) Application Receives FDA Authorization to Proceed&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 08 Oct 2025 14:15:00 +0000</pubDate>
    </item>
                                                <item>
        <title>21st Century HealthCare, Inc. Launches Full Fuel 365: Sports Performance Brand Targeting Athletes and Fitness Market</title>
                    <link>https://www.newswire.com/news/21st-century-healthcare-inc-launches-full-fuel-365-sports-performance-22653997</link>
            <guid>https://www.newswire.com/news/21st-century-healthcare-inc-launches-full-fuel-365-sports-performance-22653997</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Established healthcare leader expands into sports nutrition sector with comprehensive performance-focused product line&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 08 Oct 2025 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Navitas Life Sciences Named a Major Contender in Everest Group Clinical Data Management Operations PEAK Matrix(R) Assessment 2025</title>
                    <link>https://www.newswire.com/news/navitas-life-sciences-named-a-major-contender-in-everest-group-22651038</link>
            <guid>https://www.newswire.com/news/navitas-life-sciences-named-a-major-contender-in-everest-group-22651038</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Recognized for innovation in Biostatistics, Clinical Data Management, and Real-World Evidence, powered by AI-driven platforms&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 02 Oct 2025 19:15:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Gay Ad Network Launches First LGBTQ+ Digital Out-of-Home Advertising Solution</title>
                    <link>https://www.newswire.com/news/gay-ad-network-launches-first-lgbtq-digital-out-of-home-advertising-22646319</link>
            <guid>https://www.newswire.com/news/gay-ad-network-launches-first-lgbtq-digital-out-of-home-advertising-22646319</guid>
                <description></description>
        <pubDate>Wed, 01 Oct 2025 11:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Neurovation Labs Joins NewYorkBIO Fellows Program to Accelerate Development of Biomarker-Driven Neuromedicines and Diagnostics</title>
                    <link>https://www.newswire.com/news/neurovation-labs-joins-newyorkbio-fellows-program-to-accelerate-22648575</link>
            <guid>https://www.newswire.com/news/neurovation-labs-joins-newyorkbio-fellows-program-to-accelerate-22648575</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Company to attend upcoming NewYorkBIO Innovation Summit on September 30, 2025, in New York City&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Mon, 29 Sep 2025 15:25:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Faro Wins CDISC 2025 AI Innovation Challenge for Protocol Library Solution</title>
                    <link>https://www.newswire.com/news/faro-wins-cdisc-2025-ai-innovation-challenge-for-protocol-library-22647080</link>
            <guid>https://www.newswire.com/news/faro-wins-cdisc-2025-ai-innovation-challenge-for-protocol-library-22647080</guid>
                <description></description>
        <pubDate>Mon, 29 Sep 2025 11:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>DistillerSR Launches First-of-Its-Kind Agentic AI Capabilities  to Eliminate Evidence Silos and Accelerate Time to Market</title>
                    <link>https://www.newswire.com/news/distillersr-launches-first-of-its-kind-agentic-ai-capabilities-to-22641300</link>
            <guid>https://www.newswire.com/news/distillersr-launches-first-of-its-kind-agentic-ai-capabilities-to-22641300</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;New Capabilities Place Peer-reviewed Literature Review Evidence at the Fingertips of Research and Commercial Teams to Align Decision-making and Improve Productivity&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 17 Sep 2025 14:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Rancho Biosciences Expands Leadership in Biomedical Ontology With Appointment of Dr. Jane Lomax</title>
                    <link>https://www.newswire.com/news/rancho-biosciences-expands-leadership-in-biomedical-ontology-with-22634787</link>
            <guid>https://www.newswire.com/news/rancho-biosciences-expands-leadership-in-biomedical-ontology-with-22634787</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Industry-recognized expert SciBite, &lt;/strong&gt;&lt;/i&gt;&lt;strong&gt;and Pistoia Alliance Board Member, &lt;/strong&gt;&lt;i&gt;&lt;strong&gt;joins Rancho to advance structured data solutions for life sciences innovation&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 17 Sep 2025 12:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Longwood Healthcare Leaders to Host Boston CEO, Off-the-Record Networking and Discussion Forum, Convening Life Science Thought Leaders</title>
                    <link>https://www.newswire.com/news/longwood-healthcare-leaders-to-host-boston-ceo-off-the-record-22628526</link>
            <guid>https://www.newswire.com/news/longwood-healthcare-leaders-to-host-boston-ceo-off-the-record-22628526</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Leading life science executives, government officials, academic leaders, and investors gather for two day off-the-record networking and discussion forum&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 16 Sep 2025 11:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Aprecia and Apprentice.io Partner to Scale Pharmaceutical 3D Printing Manufacturing</title>
                    <link>https://www.newswire.com/news/arecia-and-apprentice-io-partner-to-scale-pharmaceutical-3d-printing-22640492</link>
            <guid>https://www.newswire.com/news/arecia-and-apprentice-io-partner-to-scale-pharmaceutical-3d-printing-22640492</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Aprecia will use Apprentice.io&#039;s AI-powered platform to scale its innovative technology for drug delivery solutions&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 16 Sep 2025 10:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Canyon Labs Elevates Leadership to Unite Sites and Strengthen Client Partnerships</title>
                    <link>https://www.newswire.com/news/canyon-labs-elevates-leadership-to-unite-sites-and-strengthen-client-22637950</link>
            <guid>https://www.newswire.com/news/canyon-labs-elevates-leadership-to-unite-sites-and-strengthen-client-22637950</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Strategic leadership changes align with Canyon Labs&#039; vision to scale services while strengthening its commitment to customer partnerships.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Fri, 12 Sep 2025 12:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>PharmaNest, NIH and VCU Launch Confirmatory Retrospective Outcome Study With 1,765 Patients to Advance AI-Driven Digital Pathology in MASLD</title>
                    <link>https://www.newswire.com/news/pharmanest-nih-and-vcu-launch-confirmatory-outcome-study-to-advance-ai-22638379</link>
            <guid>https://www.newswire.com/news/pharmanest-nih-and-vcu-launch-confirmatory-outcome-study-to-advance-ai-22638379</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;PharmaNest Inc. announced today a multi-institutional research collaboration with Virginia Commonwealth University (VCU) and the National Institutes of Health (NIH) to confirm the prognostic performance of artificial intelligence (AI) powered digital pathology biomarkers in metabolic dysfunction-associated steatotic liver disease (MASLD) in a retrospective cohort of 1,765 patients with MASH (NASH CRN DB2 Cohort)&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 11 Sep 2025 21:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Moolec Science Secures Regulatory Approval for Safflower GLASO Technology in Argentina, Expands U.S. Acreage, and Strengthens Leadership With CFO Appointment</title>
                    <link>https://www.newswire.com/news/moolec-science-secures-regulatory-approval-for-safflower-glaso-22638038</link>
            <guid>https://www.newswire.com/news/moolec-science-secures-regulatory-approval-for-safflower-glaso-22638038</guid>
                <description></description>
        <pubDate>Thu, 11 Sep 2025 11:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Pharma Executives Redefine IT Priorities: Five Stats Signal Urgent Tech Shift</title>
                    <link>https://www.newswire.com/news/pharma-executives-redefine-it-priorities-five-stats-signal-urgent-tech-22637222</link>
            <guid>https://www.newswire.com/news/pharma-executives-redefine-it-priorities-five-stats-signal-urgent-tech-22637222</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Black Book Research Q2-Q3 proprietary surveys reveal digital health, cybersecurity, and data platforms as the foundation of pharma&#039;s future competitiveness&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Wed, 10 Sep 2025 18:30:00 +0000</pubDate>
    </item>
                                                <item>
        <title>PillSafe Launches SAFE Investment Opportunity to Advance the First Wireless Smart Prescription Bottle Technology System</title>
                    <link>https://www.newswire.com/news/pillsafe-launches-safe-investment-opportunity-to-advance-the-first-22634777</link>
            <guid>https://www.newswire.com/news/pillsafe-launches-safe-investment-opportunity-to-advance-the-first-22634777</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Launch timetable is now imminent for developers of a revolutionary system for medication management as they open an initial SAFE investment round and will fund final product development and market validation in compelling use-case.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 09 Sep 2025 12:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>DistillerSR Unveils Ready-to-Deploy EU-MDR Literature Review Workflows to Accelerate Notified Body Submissions</title>
                    <link>https://www.newswire.com/news/distillersr-unveils-ready-to-deploy-eu-mdr-literature-review-workflows-22634391</link>
            <guid>https://www.newswire.com/news/distillersr-unveils-ready-to-deploy-eu-mdr-literature-review-workflows-22634391</guid>
                <description></description>
        <pubDate>Thu, 04 Sep 2025 14:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Pace Life Sciences to Hold Free Virtual Webinar Through Outsourced Pharma on USP Guidelines for Extractable and Leachable Manufacturing Risk Assessment</title>
                    <link>https://www.newswire.com/news/pace-life-sciences-to-hold-free-virtual-webinar-through-outsourced-22634325</link>
            <guid>https://www.newswire.com/news/pace-life-sciences-to-hold-free-virtual-webinar-through-outsourced-22634325</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Pace&amp;reg; expert to leverage extensive knowledge to provide guidance on risk assessments for pharmaceutical and biopharmaceutical companies&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 04 Sep 2025 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Finetech Launches New Technology for NJP-1200 Capsule Filling Equipment, Achieve Soft Capsule+Granule Into One Hard Capsule</title>
                    <link>https://www.newswire.com/news/finetech-launches-new-technology-for-njp-1200-capsule-filling-22633316</link>
            <guid>https://www.newswire.com/news/finetech-launches-new-technology-for-njp-1200-capsule-filling-22633316</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Finetech, a top manufacturer of pharmaceutical machinery, announces its new technology for the NJP 1200 capsule filling machine. This machine can fuse soft capsule + granule into one hard capsule.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 04 Sep 2025 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>PLPC-DB: De-Risked Oncology Immunotherapy Asset With Global Licensing Window and STIP-NAM Framework</title>
                    <link>https://www.newswire.com/news/plpc-db-de-risked-oncology-immunotherapy-asset-with-global-licensing-22633315</link>
            <guid>https://www.newswire.com/news/plpc-db-de-risked-oncology-immunotherapy-asset-with-global-licensing-22633315</guid>
                <description></description>
        <pubDate>Wed, 03 Sep 2025 12:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>ISPOR&#039;s Oncology and Statistical Methods Special Interest Groups Selects DistillerSR for Joint Systematic Review Project</title>
                    <link>https://www.newswire.com/news/ispors-oncology-and-statistical-methods-special-interest-groups-22627993</link>
            <guid>https://www.newswire.com/news/ispors-oncology-and-statistical-methods-special-interest-groups-22627993</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Leading Pharmaceutical Manufacturers, Contract Research Organizations, and Academic Medical Centers Collaborate on Global Research Project Using DistillerSR.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 21 Aug 2025 14:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Pace Life Sciences&#039; San Germán Site Receives Positive Inspection From FDA</title>
                    <link>https://www.newswire.com/news/pace-life-sciences-san-germ-n-site-receives-positive-inspection-from-22627310</link>
            <guid>https://www.newswire.com/news/pace-life-sciences-san-germ-n-site-receives-positive-inspection-from-22627310</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Company commitment to quality excellence confirmed during FDA Inspection&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 21 Aug 2025 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Belhaven Biopharma Closes Oversubscribed Series a to Fund the Development of Nasdepi(R) Program Moves Into Late Stage Clinical and Manufacturing Through NDA Approval</title>
                    <link>https://www.newswire.com/news/belhaven-biopharma-closes-oversubscribed-series-a-to-fund-the-22626950</link>
            <guid>https://www.newswire.com/news/belhaven-biopharma-closes-oversubscribed-series-a-to-fund-the-22626950</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Accelerated Round Completion Positions Company for New Drug Application (NDA) Submission and Commercial Launch Partnerships&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 19 Aug 2025 14:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Nutrishare Acquires Select Coram(R) Pharmacy Assets to Expand Services Nationwide and Open New Pharmacy in Arizona</title>
                    <link>https://www.newswire.com/news/nutrishare-acquires-select-coram-r-pharmacy-assets-to-expand-services-22625290</link>
            <guid>https://www.newswire.com/news/nutrishare-acquires-select-coram-r-pharmacy-assets-to-expand-services-22625290</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;New Arizona site represents Nutrishare&#039;s third pharmacy to support its ability to serve home TPN patients in all 50 states&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Fri, 15 Aug 2025 12:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Pace Life Sciences Debuts Enhanced cGMP Manufacturing Capabilities to Support Increasing Demand for Sterile Injectables</title>
                    <link>https://www.newswire.com/news/pace-life-sciences-debuts-enhanced-cgmp-manufacturing-capabilities-to-22622033</link>
            <guid>https://www.newswire.com/news/pace-life-sciences-debuts-enhanced-cgmp-manufacturing-capabilities-to-22622033</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Company Reopens State-of-the-Art Isolated Vial Filling Line at Aseptic Fill-Finish Center of Excellence&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 12 Aug 2025 13:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Vodori Debuts on AppExchange, Modernizing Compliant Content Delivery for Life Sciences</title>
                    <link>https://www.newswire.com/news/vodori-debuts-on-appexchange-modernizing-compliant-content-delivery-22570309</link>
            <guid>https://www.newswire.com/news/vodori-debuts-on-appexchange-modernizing-compliant-content-delivery-22570309</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Vodori&#039;s app will deliver content access directly inside Salesforce, streamlining content approval-to-distribution workflows for life sciences teams seeking agility over complexity.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 12 Aug 2025 12:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Behemoth Labz GLP-1 Nasal Spray Review for Researchers</title>
                    <link>https://www.newswire.com/news/behemoth-labz-glp-1-nasal-spray-review-for-researchers-22622053</link>
            <guid>https://www.newswire.com/news/behemoth-labz-glp-1-nasal-spray-review-for-researchers-22622053</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Explores Behemoth Labz GLP‑1 nasal formulation&#039;s structural design, analytic insights, and intranasal incretin research relevance in preclinical metabolic modeling.&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Thu, 07 Aug 2025 23:45:00 +0000</pubDate>
    </item>
                                                <item>
        <title>ForCast Orthopedics Announces Initial Close of Series A Financing Round to Advance Novel Therapies for PJI</title>
                    <link>https://www.newswire.com/news/forcast-orthopedics-announces-initial-close-of-series-a-financing-22620793</link>
            <guid>https://www.newswire.com/news/forcast-orthopedics-announces-initial-close-of-series-a-financing-22620793</guid>
                <description></description>
        <pubDate>Tue, 05 Aug 2025 17:00:00 +0000</pubDate>
    </item>
                                                <item>
        <title>Sia/LBG Receives Supplemental Grant to Expand Features for Global Health Cost Model Platform</title>
                    <link>https://www.newswire.com/news/sia-lbg-receives-supplemental-grant-to-expand-features-for-global-22615872</link>
            <guid>https://www.newswire.com/news/sia-lbg-receives-supplemental-grant-to-expand-features-for-global-22615872</guid>
                <description>&lt;p&gt;&lt;i&gt;&lt;strong&gt;Sia/LBG has been awarded a supplemental grant by the Gates Foundation to enhance its web-based cost and environmental impact modeling resource for pharmaceutical APIs Cost of Goods (COGs).&lt;/strong&gt;&lt;/i&gt;&lt;/p&gt;</description>
        <pubDate>Tue, 29 Jul 2025 14:00:00 +0000</pubDate>
    </item>
                        
</channel>
</rss>
